期刊文献+

Gastric cancer stem cells in gastric carcinogenesis,progression,prevention and treatment 被引量:10

Gastric cancer stem cells in gastric carcinogenesis,progression,prevention and treatment
下载PDF
导出
摘要 In recent decades,the study of the mechanism of tumorigenesis has brought much progress to cancer treatment.However,cancer stem cell(CSC)theory has changed previous views of tumors,and has provided a new method for treatment of cancer.The discovery of CSCs and their characteristics have contributed to understanding the molecular mechanism of tumor genesis and development,resulting in a new effective strategy for cancer treatment.Gastric CSCs(GCSCs)are the basis for the onset of gastric cancer.They may be derived from gastric stem cells in gastric tissues,or bone marrow mesenchymal stem cells.As with other stem cells,GCSCs highly express drug-resistance genes such as aldehyde dehydrogenase and multidrug resistance,which are resistant to chemotherapy and thus form the basis of drug resistance.Many specific molecular markers such as CD44 and CD133 have been used for identification and isolation of GCSCs,diagnosis and grading of gastric cancer,and research on GCSC-targeted therapy for gastric cancer.Therefore,discussion of the recent development and advancements in GCSCs will be helpful for providing novel insight into gastric cancer treatment. In recent decades, the study of the mechanism of tumorigenesis has brought much progress to cancer treatment. However, cancer stem cell (CSC) theory has changed previous views of tumors, and has provided a new method for treatment of cancer. The discovery of CSCs and their characteristics have contributed to understanding the molecular mechanism of tumor genesis and development, resulting in a new effective strategy for cancer treatment. Gastric CSCs (GCSCs) are the basis for the onset of gastric cancer. They may be derived from gastric stem cells in gastric tissues, or bone marrow mesenchymal stem cells. As with other stem cells, GCSCs highly express drug-resistance genes such as aldehyde dehydrogenase and multidrug resistance, which are resistant to chemotherapy and thus form the basis of drug resistance. Many specific molecular markers such as CD44 and CD133 have been used for identification and isolation of GCSCs, diagnosis and grading of gastric cancer, and research on GCSC-targeted therapy for gastric cancer. Therefore, discussion of the recent development and advancements in GCSCs will be helpful for providing novel insight into gastric cancer treatment.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第18期5420-5426,共7页 世界胃肠病学杂志(英文版)
关键词 CANCER STEM cells GASTRIC CANCER DRUG resistance C Cancer stem cells, Gastric cancer, Drug resistance, Cancer treatment, Molecular mechanism
  • 相关文献

参考文献13

  • 1Tian Tian,Yajie Zhang,Shouyu Wang,Jianwei Zhou,Shan Xu.Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer[J].The Journal of Biomedical Research,2012,26(5):336-345. 被引量:12
  • 2Jun-Jun She Peng-Ge Zhang Xuan Wang Xiang-Ming Che Zi-Ming Wang.Side population cells isolated from KATO Ⅲ human gastric cancer cell line have cancer stem cell-like characteristics[J].World Journal of Gastroenterology,2012,18(33):4610-4617. 被引量:20
  • 3Alba Rocco,Debora Compare,Gerardo Nardone.Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions[J].World Journal of Gastrointestinal Oncology,2012,4(3):54-59. 被引量:11
  • 4Charles S Fuchs,Jiri Tomasek,Cho Jae Yong,Filip Dumitru,Rodolfo Passalacqua,Chanchal Goswami,Howard Safran,Lucas Vieira dos Santos,Giuseppe Aprile,David R Ferry,Bohuslav Melichar,Mustapha Tehfe,Eldar Topuzov,John Raymond Zalcberg,Ian Chau,William Campbell,Choondal Sivanandan,Joanna Pikiel,Minori Koshiji,Yanzhi Hsu,Astra M Liepa,Ling Gao,Jonathan D Schwartz,Josep Tabernero.Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial[J].The Lancet.2014(9911)
  • 5Sarah Shigdar,Yong Li,Santanu Bhattacharya,Michael O’Connor,Chunwen Pu,Jia Lin,Tao Wang,Dongxi Xiang,Lingxue Kong,Ming Q. Wei,Yimin Zhu,Shufeng Zhou,Wei Duan.Inflammation and cancer stem cells[J].Cancer Letters.2014(2)
  • 6Xiaodi Ding,Xiujuan Qu,Yibo Fan,Xiaofang Che,Jinglei Qu,Ling Xu,Jing Liu,Yunpeng Liu.Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells[J].Anti-Cancer Drugs.2014(3)
  • 7Kousuke Hashimoto,Keishiro Aoyagi,Taro Isobe,Kikuo Kouhuji,Kazuo Shirouzu.Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer[J].Gastric Cancer.2014(1)
  • 8Slavica Stojnev,Miljan Krstic,Ana Ristic-Petrovic,Vladisav Stefanovic,Takanori Hattori.Gastric cancer stem cells: therapeutic targets[J].Gastric Cancer.2014(1)
  • 9Qin Liu,Ru-Tian Li,Han-Qing Qian,Jia Wei,Li Xie,Jie Shen,Mi Yang,Xiao-Ping Qian,Li-Xia Yu,Xi-Qun Jiang,Bao-Rui Liu.Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles[J].Biomaterials.2013(29)
  • 10Youngmi Kim,Qiulian Wu,Petra Hamerlik,Masahiro Hitomi,Andrew E. Sloan,Gene H. Barnett,Robert J. Weil,Patrick Leahy,Anita B. Hjelmeland,Jeremy N. Rich.Aptamer Identification of Brain Tumor–Initiating Cells[J].Cancer Research.2013(15)

二级参考文献79

  • 1徐艳琼,李爱萍,陈瑞,周建伟.JWA在N-甲基-N’-硝基-N-亚硝基胍诱导的人支气管上皮细胞凋亡中的作用[J].中华劳动卫生职业病杂志,2006,24(4):205-208. 被引量:4
  • 2Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Nail Acad Sci USA 2003; 100: 3983-3988.
  • 3Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide I, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
  • 4Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.
  • 5Fang O, Nguyen IK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M. A tumorigenic subpopulation with stern cell properties in melanomas. Cancer Res 2005; 65: 9328-9337.
  • 6Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F. Cancer stern cell characteristics in retinoblastoma. Mol Vis 2005; 11: 729-737.
  • 7Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RI, Jacks I. Identification of bronchioalveolar stern cells in normal lung and lung cancer. Cell 2005; 121: 823-835.
  • 8Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
  • 9Kayo H, Yamazaki H, Nishida H, Dang NH, Morimoto C. Stern cell properties and the side population cells as a target for interferon-alpha in adult I-cell leukemia/lymphoma. Biochem Biophys Res Commun 2007; 364: 808-814.
  • 10Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stern cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806.

共引文献43

同被引文献131

  • 1石保艳,吴金华.替吉奥治疗老年晚期胃癌的疗效[J].医学信息(医学与计算机应用),2014,0(3):285-285. 被引量:1
  • 2Kyle J Napier,Mary Scheerer,Subhasis Misra.Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities[J].World Journal of Gastrointestinal Oncology,2014,6(5):112-120. 被引量:93
  • 3Bo Li, Tian Ye, Lei Zhao, De-Hua Li, Xing-Hua Gou, Lan-Ying Zhao, Lei Han, Lin Chen, Lu-Nan Yan and Jian-Ping Gong Department of Hepatobiliary Surgery, Second Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400010, China ,Department of Traditional Chinese Surgery, Second Affiliated Hospital, Luzhou Medical College, Luzhou 646000, China ,Genetic Engineering Laboratory, Chengdu Di’ao Group Co., Ltd., Chengdu 610041, China Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):552-559. 被引量:10
  • 4Ramon Andrade de Mello,Andrea Marin Marques,António Araújo.HER2 therapies and gastric cancer:A step forward[J].World Journal of Gastroenterology,2013,19(37):6165-6169. 被引量:7
  • 5Girieca Lorusso,Curzio Rüegg.The tumor microenvironment and its contribution to tumor evolution toward metastasis[J]. Histochemistry and Cell Biology . 2008 (6)
  • 6Andrew D. Rhim,Emily T. Mirek,Nicole M. Aiello,Anirban Maitra,Jennifer M. Bailey,Florencia McAllister,Maximilian Reichert,Gregory L. Beatty,Anil K. Rustgi,Robert H. Vonderheide,Steven D. Leach,Ben Z. Stanger.EMT and Dissemination Precede Pancreatic Tumor Formation[J].Cell.2012(1)
  • 7William K.K. Wu,Chi H. Cho,Chung W. Lee,Daiming Fan,Kaichun Wu,Jun Yu,Joseph J.Y. Sung.Dysregulation of cellular signaling in gastric cancer[J].Cancer Letters.2010(2)
  • 8Shou-mei Yang,Cheng Huang,Xiao-feng Li,Ming-zhe Yu,Yong He,Jun Li.miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN[J].Toxicology.2013
  • 9Zhuo Liu,Jiaming Zhu,Hong Cao,Hui Ren,Xuedong Fang.miR-10b promotes cell invasion through RhoC-AKT signaling pathway bytargeting HOXD10 in gastric cancer[J].International Journal of Oncology.2012(5)
  • 10Ksiazkiewicz, Magdalena,Markiewicz, Aleksandra,Zaczek, Anna J.Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells[J]. Pathobiology . 2012 (4)

引证文献10

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部